Invention Grant
![1-(piperazin-1-yl)-2-([1,2,4]triazol-1-yl)-ethanone derivatives](/docs/US/2019-04-16/US10259807B2/abs.jpg.600x600.jpg)
- Patent Title: 1-(piperazin-1-yl)-2-([1,2,4]triazol-1-yl)-ethanone derivatives
-
Application No.: US14906882Application Date: 2014-07-21
-
Publication No.: US10259807B2Publication Date: 2019-04-16
- Inventor: Eva Caroff , Emmanuel Meyer
- Applicant: Idorsia Pharmaceuticals Ltd.
- Applicant Address: SE Allschwil
- Assignee: IDORSIA PHARMACEUTICALS LTD.
- Current Assignee: IDORSIA PHARMACEUTICALS LTD.
- Current Assignee Address: SE Allschwil
- Agency: Arent Fox LLP
- Priority: WOPCT/IB2013/056001 20130722
- International Application: PCT/EP2014/065639 WO 20140721
- International Announcement: WO2015/011099 WO 20150129
- Main IPC: C07D417/14
- IPC: C07D417/14
![1-(piperazin-1-yl)-2-([1,2,4]triazol-1-yl)-ethanone derivatives](/abs-image/US/2019/04/16/US10259807B2/abs.jpg.150x150.jpg)
Abstract:
The invention relates to compounds of Formula (I) wherein X, Y, R1, R2, R3, R4 and R5 are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.
Public/Granted literature
- US20160176862A1 1-(PIPERAZIN-1-YL)-2-([1,2,4]TRIAZOL-1-YL)-ETHANONE DERIVATIVES Public/Granted day:2016-06-23
Information query
